http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95de465760815ddee56c95f82278f854
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Figueroa |
| name | Jonine D. Figueroa Jonine D Figueroa |
| given-name | Jonine D. Jonine D |
| organization-name | The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK. Authors' Affiliations: Department of 1Nutrition, 2Epidemiology, and 3Biostatistics, Harvard School of Public Health; 4Channing Division of Network Medicine and 5Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women's Hospital; 6Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Massachusetts; 7Division of Cancer Epidemiology and 8Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville; 10Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 11Core Genotyping Facility, Frederick National Laboratory for Cancer Research, Gaithersburg, Maryland; 12Institut National de la Santé et de la Recherche Medicale (INSERM), Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy; 13Paris South University, Villejuif; 14International Agency for Research on Cancer (IARC), Lyon, France; 15Epidemiolog Usher Institute, University of Edinburgh, UK; Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, UK. Electronic address: Jonine.figueroa@ed.ac.uk. Usher Institute and CRUK Edinburgh Centre, University of Edinburgh , Teviot Place, EH8 9AG, UK Usher Institute, University of Edinburgh, Edinburgh, UK; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville Maryland United States of America The University of Edinburgh, Usher Institute, Centre for Global Health, Edinburgh, UK Division of Cancer Epidemiology & Genetics National Cancer Institute, National Institutes of Health Bethesda Maryland USA; Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre The University of Edinburgh Edinburgh United Kingdom Division of Cancer Epidemiology & Genetics, National Cancer Institute, Maryland, USA, Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital , Edinburgh , UK; Usher Institute, Centre for Population Health Sciences, Old Medical School , Teviot Place, Edinburgh , UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Rockville, Maryland; 2Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center; 3Division of Breast Surgical Oncology, Department of Surgery, 4Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis; and 5Catherine Peachey Fund, Inc, Warsaw, Indiana Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 3Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, and Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 2Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; 3Epidemiology Research Program, American Cancer Society, Atlanta, Georgia; 4Spanish National Cancer Research Centre; 5Ramón y Cajal University Hospital, Madrid, Spain; 6Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; 7Department of Epidemiology, Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 8Centre for Research in Environmental Epidemiology (CREAL); 9CIBER Epidemiología y Salud Pública (CIBERESP); 10Universitat Pompeu Fabra; 11Hospital del Mar-Institut Municipal d'Investigació Mèdica (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; 12National School of Public Health, Athens, Greece; 13Core Genotype Facility, SAIC-Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland; 14Universidad de Oviedo, Ovie 1Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh, UK 4Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Scotland, UK. Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD; Usher Institute of Population Health Sciences and Informatics, Institute of Genomics and Molecular Medicine Edinburgh Cancer Research Centre, University of Edinburgh UK 92 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA Authors' Affiliations: 1Department of Epidemiology; 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 4Department of Biology, Trinity University, San Antonio, Texas; 5Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 6Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada; and 7Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, 2Laboratory of Pathology, and 3Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; 4University of Calgary, Calgary, Alberta, Canada; and 5Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre; 6Cancer Research UK, Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom 14Usher Institute and CRUK Edinburgh Centre, University of Edinburgh, Edinburgh, United Kingdom. Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD; Currently at the Usher Institute of Population Health Sciences and Informatics, Edinburgh Cancer Research Centre Edinburgh Scotland 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York; Departments of 2Surgery and 3Biochemistry and Molecular Biology, and 4USC Epigenome Center and USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angles, California; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; 6Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; 7Department of Occupational and Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland; and 8Department of Pathology, Yale University School of Medicine, New Haven, Connecticut Usher Institute, University of Edinburgh , Edinburgh , UK; Brain Tumor Centre of Excellence, Cancer Research UK Edinburgh Centre, University of Edinburgh , Edinburgh , UK Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA; Usher Institute and CRUK Edinburgh Centre, University of Edinburgh, Edinburgh, United Kingdom 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland. 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland; National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD, 20850, USA; The University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, EH16 4UX, UK; The University of Edinburgh, Cancer Research UK Edinburgh Centre, Edinburgh, EH4 2XR, UK. University of Edinburgh Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Usher Institute of Population Health Sciences and Informatics, Edinburgh Cancer Research Centre, Edinburgh, Scotland Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA Divsion of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD; Usher Institute of Population Health Sciences and Informatics and Edinburgh Cancer Research Centre, University of Edinburgh United Kingdom Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville MD USA 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland. Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, Scotland Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA, Authors' Affiliations: Departments of 1Pathology and 2Surgery and Oncology, Yale University School of Medicine, New Haven, Connecticut; 3Center for Biostatistics, Ohio State University, Columbus, Ohio; 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 5Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; 6Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden; 7Division of Pathology, National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, Pennsylvania; 8International Breast Cancer Foundation, Madison, Wisconsin; 9Departments of Medicine and of Molecular and Cellular Biology, and 10Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland and 2Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts Usher Institute, University of Edinburgh, Edinburgh, UK; Brain Tumour Centre of Excellence, Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK |
Incoming Links
Total number of triples: 180.